These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2179659)

  • 1. [Technical methodologic aspects of clinical dosimetry in radionuclide therapy].
    Denisenko ON; Ivanov VN; Drozdovskiĭ BIa; Nikulin IuP; Tiatte EG; Ivanova LF; Parshin VS
    Med Radiol (Mosk); 1990 Feb; 35(2):48-52. PubMed ID: 2179659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
    DeNardo GL; Siantar CL; DeNardo SJ
    Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
    Mattsson S; Johansson L; Jönsson H; Nosslin B
    Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of diagnostic and therapeutic radionuclides by US homeland security: a new travel hazard.
    Stockigt JR; Ballok Z; Kalff V
    Med J Aust; 2005 Nov; 183(10):552. PubMed ID: 16296986
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid imaging using positron emission tomography--a comparison with ultrasound imaging and conventional scintigraphy in thyrotoxicosis.
    Flower MA; Irvine AT; Ott RJ; Kabir F; McCready VR; Harmer CL; Sharma HL; Smith AG
    Br J Radiol; 1990 May; 63(749):325-30. PubMed ID: 2198979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
    Eschner W; Kobe C; Schicha H
    Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry of internal emitters.
    Sgouros G
    J Nucl Med; 2005 Jan; 46 Suppl 1():18S-27S. PubMed ID: 15653648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
    J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry prior to I-131-therapy of benign thyroid disease.
    Hänscheid H; Lassmann M; Reiners C
    Z Med Phys; 2011 Dec; 21(4):250-7. PubMed ID: 21531122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The current achievements in radiopharmaceutical dosimetry].
    Narkevich BIa
    Med Radiol (Mosk); 1991; 36(12):47-52. PubMed ID: 1749335
    [No Abstract]   [Full Text] [Related]  

  • 15. The NUKDOS software for treatment planning in molecular radiotherapy.
    Kletting P; Schimmel S; Hänscheid H; Luster M; Fernández M; Nosske D; Lassmann M; Glatting G
    Z Med Phys; 2015 Sep; 25(3):264-74. PubMed ID: 25791740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical aspects of scintigraphy-based dosimetry for nuclear medicine therapy.
    Geworski L; Schaefer A; Knoop BO; Pinkert J; Plotkin M; Kirsch CM
    Nuklearmedizin; 2010; 49(3):85-95. PubMed ID: 20505893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretherapeutic dosimetry before 131I therapy of benign thyroid disease. A clinical practice assessment of dosimetric parameters.
    Krohn T; Behrendt FF; Heinzel A; Müller B; Mottaghy FM; Verburg FA
    Nuklearmedizin; 2015; 54(3):131-6. PubMed ID: 25487217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.